Ali Canbay

20.8k total citations · 8 hit papers
387 papers, 14.7k citations indexed

About

Ali Canbay is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ali Canbay has authored 387 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Epidemiology, 170 papers in Hepatology and 124 papers in Surgery. Recurrent topics in Ali Canbay's work include Liver Disease Diagnosis and Treatment (198 papers), Liver Disease and Transplantation (104 papers) and Organ Transplantation Techniques and Outcomes (44 papers). Ali Canbay is often cited by papers focused on Liver Disease Diagnosis and Treatment (198 papers), Liver Disease and Transplantation (104 papers) and Organ Transplantation Techniques and Outcomes (44 papers). Ali Canbay collaborates with scholars based in Germany, United States and Türkiye. Ali Canbay's co-authors include Gregory J. Gores, Guido Gerken, Ariel E. Feldstein, Lars P. Bechmann, Alexander Wree, Steven F. Bronk, Jan‐Peter Sowa, Hajime Higuchi, Hal M. Hoffman and Wing‐Kin Syn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ali Canbay

361 papers receiving 14.4k citations

Hit Papers

Hepatocyte apoptosis and ... 2003 2026 2010 2018 2003 2013 2011 2004 2013 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ali Canbay 9.0k 5.1k 3.8k 2.9k 2.3k 387 14.7k
Fabio Marra 10.4k 1.2× 8.1k 1.6× 3.7k 1.0× 3.0k 1.0× 2.2k 1.0× 280 17.9k
Marco Arrese 6.8k 0.8× 2.9k 0.6× 2.2k 0.6× 2.7k 0.9× 2.4k 1.0× 243 11.0k
Matthew M. Yeh 13.4k 1.5× 5.9k 1.2× 3.5k 0.9× 3.0k 1.0× 4.5k 2.0× 129 17.2k
Jacob George 11.6k 1.3× 6.4k 1.2× 2.0k 0.5× 1.9k 0.6× 4.1k 1.8× 275 15.4k
Philip N. Newsome 8.9k 1.0× 5.0k 1.0× 3.1k 0.8× 3.6k 1.2× 5.0k 2.2× 215 14.6k
Isabelle Leclercq 5.5k 0.6× 2.8k 0.6× 2.7k 0.7× 1.9k 0.7× 1.8k 0.8× 161 9.6k
Manuel Romero‐Gómez 11.1k 1.2× 8.0k 1.6× 1.5k 0.4× 2.5k 0.9× 3.0k 1.3× 375 14.7k
Alastair D. Burt 12.2k 1.4× 8.5k 1.7× 2.7k 0.7× 3.2k 1.1× 3.8k 1.7× 238 18.4k
Cynthia Behling 12.5k 1.4× 5.8k 1.1× 2.4k 0.6× 2.6k 0.9× 4.8k 2.1× 96 15.6k
Koichi Tsuneyama 5.3k 0.6× 4.7k 0.9× 3.3k 0.9× 3.7k 1.3× 874 0.4× 448 15.3k

Countries citing papers authored by Ali Canbay

Since Specialization
Citations

This map shows the geographic impact of Ali Canbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Canbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Canbay more than expected).

Fields of papers citing papers by Ali Canbay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Canbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Canbay. The network helps show where Ali Canbay may publish in the future.

Co-authorship network of co-authors of Ali Canbay

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Canbay. A scholar is included among the top collaborators of Ali Canbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Canbay. Ali Canbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaya, Eda, et al.. (2025). Hypertriglyceridemia Screening in Acute Pancreatitis: Diagnostic Blind Spot in Clinical Routine. Digestive Diseases and Sciences. 71(2). 709–715.
2.
Streichert, Thomas, et al.. (2025). Hierarchy of reference interval models: advancing laboratory data interpretation. Clinical Chemistry and Laboratory Medicine (CCLM). 64(4). 781–791.
3.
Özçürümez, Mustafa, et al.. (2024). Abklärung erhöhter Leberwerte. CME. 21(9). 23–33.
4.
Sydor, Svenja, Jan Best, Martin Steinmetz, et al.. (2024). Religious intermittent fasting: Effects on liver health, metabolic markers, and gut microbiota in type 2 diabetes patients. Clinical Nutrition Open Science. 58. 370–383. 2 indexed citations
6.
Brol, Maximilian Joseph, Ali Canbay, & Jonel Trebicka. (2024). Alcohol-associated hepatitis: a neutrophile disease?. Gut. 74(1). 6–8. 2 indexed citations
7.
Leyh, Catherine, Jason D. Coombes, Hartmut Schmidt, et al.. (2024). MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine. 14(4). 370–370. 15 indexed citations
8.
Özçürümez, Mustafa, Abdurrahman Coşkun, Farhad Arzideh, et al.. (2024). Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps. Clinical Chemistry and Laboratory Medicine (CCLM). 63(3). 587–599. 1 indexed citations
9.
Özçürümez, Mustafa, Abdurrahman Coşkun, Farhad Arzideh, et al.. (2024). Time-dependent characteristics of analytical measurands. Clinical Chemistry and Laboratory Medicine (CCLM). 62(12). 2485–2497. 1 indexed citations
10.
Akkız, Hikmet, Robert K. Gieseler, & Ali Canbay. (2024). Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells. International Journal of Molecular Sciences. 25(14). 7873–7873. 47 indexed citations breakdown →
11.
Schwertheim, Suzan, Paul Manka, Jan‐Peter Sowa, et al.. (2023). Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels. Journal of Personalized Medicine. 13(7). 1152–1152. 3 indexed citations
12.
Sowa, Jan‐Peter, et al.. (2023). Mechanisms and aetiology‐dependent treatment of acute liver failure. Liver International. 45(3). e15739–e15739. 8 indexed citations
13.
Hoffmann, Armin, et al.. (2023). Whipple’s Disease – delay of diagnosis by immunosuppressive therapy; a case-series report. Zeitschrift für Gastroenterologie. 61(8). 1002–1008. 1 indexed citations
14.
Jahn, Michael, Mustafa Özçürümez, Sebastian Dolff, et al.. (2022). A Multipathogen Bile Sample-based PCR Assay Can Guide Empirical Antimicrobial Strategies in Cholestatic Liver Diseases. Journal of Clinical and Translational Hepatology. 10(5). 788–795. 1 indexed citations
15.
Schotten, Clemens, Jan‐Peter Sowa, Paul Manka, et al.. (2021). GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals. 14(8). 735–735. 34 indexed citations
16.
Aweimer, Assem, Peter Haldenwang, Justus T. Strauch, et al.. (2021). Incidence and Impact of Routine Inflammatory Parameters on Outcome after Transcatheter Aortic Valve Replacement. Journal of Interventional Cardiology. 2021. 1–5. 4 indexed citations
17.
Jahn, Michael, Jan Rekowski, Rolf Alexander Jánosi, et al.. (2020). Score performance of SAPS 2 and SAPS 3 in combination with biomarkers IL-6, PCT or CRP. PLoS ONE. 15(9). e0238587–e0238587. 3 indexed citations
18.
Jahn, Michael, Jan Rekowski, Guido Gerken, et al.. (2019). The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis. PLoS ONE. 14(9). e0222164–e0222164. 15 indexed citations
19.
Beilfuss, A, Jan‐Peter Sowa, Svenja Sydor, et al.. (2014). Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 64(5). 791–799. 120 indexed citations
20.
Çelebi, Özlem Özcan, Nermin Bayar, Ali Canbay, et al.. (2007). Spontan koroner arter disseksiyonu. 7(3). 320–322. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026